Skip to main content
Top
Published in: Modern Rheumatology 3/2009

01-06-2009 | Original Article

Sixty percent of patients with rheumatoid arthritis in Japan have used dietary supplements or health foods

Authors: Shoichiro Ikuyama, Emiko Imamura-Takase, Shoji Tokunaga, Motohiro Oribe, Junji Nishimura

Published in: Modern Rheumatology | Issue 3/2009

Login to get access

Abstract

We conducted a survey on the use of dietary supplements and health foods (DS/HF) in definite rheumatoid arthritis (RA) patients treated by RA specialists. Among 296 patients (male 48, female 248), 179 patients (60.5%) had experience of DS/HF use. Prevalence of DS/HF use was significantly higher in female than in male patients (63.7% versus 43.8%). Overall, patients who have used DS/HF were significantly younger than those who have not used; it was particularly notable in female patients. The proportion of current users was significantly higher in those less than 5 years from diagnosis than those who had been diagnosed for 5 years or more. Products of herbs or algae (44.1%) and components of cartilage (40.8%) were the most popular DS/HF. Primary sources of product information were family members or friends (56.4%) and advertisements in the mass media (34.1%). Of the users, 73.7% did not disclose DS/HF use to their physicians. The users expected alleviation of the symptoms (35.2%) and improvement of health (34.6%). However, 59.2% of the users were unsure of the benefits. In conclusion, physicians should be aware of the high prevalence of DS/HF usage in patients with RA in Japan.
Literature
1.
go back to reference Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med. 1993;328:246–52.PubMedCrossRef Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med. 1993;328:246–52.PubMedCrossRef
3.
go back to reference Struthers GR, Scott DL, Scott DGI. The use of ‘alternative treatments’ by patients with rheumatoid arthritis. Rheumatol Int. 1983;3:151–2.PubMedCrossRef Struthers GR, Scott DL, Scott DGI. The use of ‘alternative treatments’ by patients with rheumatoid arthritis. Rheumatol Int. 1983;3:151–2.PubMedCrossRef
4.
go back to reference Boisset M, Fitscharles M-A. Alternative medicine use by rheumatology patients in a universal health care setting. J Rheumatol. 1994;21:148–52.PubMed Boisset M, Fitscharles M-A. Alternative medicine use by rheumatology patients in a universal health care setting. J Rheumatol. 1994;21:148–52.PubMed
5.
go back to reference Rao JK, Mihaliak K, Kroenke K, Bradley J, Tierney WM, Weinberger M. Use of complementary therapies for arthritis among patients of rheumatologists. Ann Intern Med. 1999;131:409–16.PubMed Rao JK, Mihaliak K, Kroenke K, Bradley J, Tierney WM, Weinberger M. Use of complementary therapies for arthritis among patients of rheumatologists. Ann Intern Med. 1999;131:409–16.PubMed
6.
go back to reference Fautrel B, Adam V, St-Pierre Y, Joseph L, Clarke AE, Penrod JR. Use of complementary and alternative therapies by patients self-reporting arthritis or rheumatism: results from a nationwide Canadian survey. J Rheumatol. 2002;29:2435–41.PubMed Fautrel B, Adam V, St-Pierre Y, Joseph L, Clarke AE, Penrod JR. Use of complementary and alternative therapies by patients self-reporting arthritis or rheumatism: results from a nationwide Canadian survey. J Rheumatol. 2002;29:2435–41.PubMed
7.
go back to reference Chandrashekara S, Anilkumar T, Jamuna S. Complementary and alternative drug therapy in arthritis. J Assoc Physicians India. 2002;50:225–7.PubMed Chandrashekara S, Anilkumar T, Jamuna S. Complementary and alternative drug therapy in arthritis. J Assoc Physicians India. 2002;50:225–7.PubMed
8.
go back to reference Rao JK, Kroenke K, Mihaliak KA, Grambow SC, Weinberger M. Rheumatology patients’ use of complementary therapies: results from a one-year longitudinal study. Arthritis Rheum. 2003;49:619–25.PubMedCrossRef Rao JK, Kroenke K, Mihaliak KA, Grambow SC, Weinberger M. Rheumatology patients’ use of complementary therapies: results from a one-year longitudinal study. Arthritis Rheum. 2003;49:619–25.PubMedCrossRef
9.
go back to reference Kim HA, Seo YI. Use of complementary and alternative medicine by arthritis patients in a university hospital clinic serving rheumatology patients in Korea. Rheumatol Int. 2003;23:277–81.PubMedCrossRef Kim HA, Seo YI. Use of complementary and alternative medicine by arthritis patients in a university hospital clinic serving rheumatology patients in Korea. Rheumatol Int. 2003;23:277–81.PubMedCrossRef
10.
go back to reference Herman CJ, Allen P, Hunt WC, Prasad A, Brady TJ. Use of complementary therapies among primary care clinic patients with arthritis. Prev Chronic Dis. 2004;1:1–15. Herman CJ, Allen P, Hunt WC, Prasad A, Brady TJ. Use of complementary therapies among primary care clinic patients with arthritis. Prev Chronic Dis. 2004;1:1–15.
11.
go back to reference Breuer GS, Orbach H, Elkayam O, Berkun Y, Paran D, Mates M, et al. Use of complementary and alternative medicine among patients attending rheumatology clinics in Israel. Isr Med Assoc J. 2006;8:184–7.PubMed Breuer GS, Orbach H, Elkayam O, Berkun Y, Paran D, Mates M, et al. Use of complementary and alternative medicine among patients attending rheumatology clinics in Israel. Isr Med Assoc J. 2006;8:184–7.PubMed
12.
go back to reference Yamashita H, Tsukayama H, Sugishita C. Popularity of complementary and alternative medicine in Japan: a telephone survey. Complement Ther Med. 2002;10:84–93.PubMedCrossRef Yamashita H, Tsukayama H, Sugishita C. Popularity of complementary and alternative medicine in Japan: a telephone survey. Complement Ther Med. 2002;10:84–93.PubMedCrossRef
13.
go back to reference Kajiyama H, Akama H, Yamanaka H, Shoji A, Matsuda Y, Tanaka E, et al. One third of Japanese patients with rheumatoid arthritis use complementary and alternative medicine. Mod Rheumatol. 2006;16:355–9.PubMedCrossRef Kajiyama H, Akama H, Yamanaka H, Shoji A, Matsuda Y, Tanaka E, et al. One third of Japanese patients with rheumatoid arthritis use complementary and alternative medicine. Mod Rheumatol. 2006;16:355–9.PubMedCrossRef
14.
go back to reference Hyodo I, Amano N, Eguchi K, Narabayashi M, Imanishi J, Hirai M, et al. Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol. 2005;23:2645–54.PubMedCrossRef Hyodo I, Amano N, Eguchi K, Narabayashi M, Imanishi J, Hirai M, et al. Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol. 2005;23:2645–54.PubMedCrossRef
15.
go back to reference McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis: a systemic quality assessment and meta-analysis. JAMA. 2000;283:1469–75.PubMedCrossRef McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis: a systemic quality assessment and meta-analysis. JAMA. 2000;283:1469–75.PubMedCrossRef
16.
go back to reference Clegg DO, Reda DJ, Harris CL, Klein MA, O’Dell JR, Hooper MM, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006;354:795–808.PubMedCrossRef Clegg DO, Reda DJ, Harris CL, Klein MA, O’Dell JR, Hooper MM, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006;354:795–808.PubMedCrossRef
17.
go back to reference Nakamura H, Masuko K, Yudoh K, Kato T, Kamada T, Kawahara T. Effects of glucosamine administration on patients with rheumatoid arthritis. Rheumatol Int. 2007;27:213–8.PubMedCrossRef Nakamura H, Masuko K, Yudoh K, Kato T, Kamada T, Kawahara T. Effects of glucosamine administration on patients with rheumatoid arthritis. Rheumatol Int. 2007;27:213–8.PubMedCrossRef
18.
go back to reference Ariza-Ariza R, Mestanza-Peralta M, Cardiel MH. Omega-3 fatty acids in rheumatoid arthritis: an overview. Semin Arthritis Rheum. 1998;27:366–70.PubMedCrossRef Ariza-Ariza R, Mestanza-Peralta M, Cardiel MH. Omega-3 fatty acids in rheumatoid arthritis: an overview. Semin Arthritis Rheum. 1998;27:366–70.PubMedCrossRef
19.
go back to reference Geusens P, Wouters C, Nijs J, Jiang Y, Dequeker J. Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. Arthritis Rheum. 1994;37:824–9.PubMedCrossRef Geusens P, Wouters C, Nijs J, Jiang Y, Dequeker J. Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. Arthritis Rheum. 1994;37:824–9.PubMedCrossRef
20.
go back to reference Berbert AA, Kondo CRM, Almendra CL, Matsuo T, Dichi I. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis. Nutrition. 2005;21:131–6. Berbert AA, Kondo CRM, Almendra CL, Matsuo T, Dichi I. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis. Nutrition. 2005;21:131–6.
21.
go back to reference Galarraga B, Ho M, Youssef HM, Hill A, McMahon H, Hall C, et al. Cod liver oil (n-3 fatty acids) as an non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis. Rheumatology. 2008;47:665–9.PubMedCrossRef Galarraga B, Ho M, Youssef HM, Hill A, McMahon H, Hall C, et al. Cod liver oil (n-3 fatty acids) as an non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis. Rheumatology. 2008;47:665–9.PubMedCrossRef
22.
go back to reference Brzeski M, Madhok R, Capell HA. Evening primrose oil in patients with rheumatoid arthritis and side-effects of non-steroidal anti-inflammatory drugs. Br J Rheumatol. 1991;30:370–2.PubMedCrossRef Brzeski M, Madhok R, Capell HA. Evening primrose oil in patients with rheumatoid arthritis and side-effects of non-steroidal anti-inflammatory drugs. Br J Rheumatol. 1991;30:370–2.PubMedCrossRef
Metadata
Title
Sixty percent of patients with rheumatoid arthritis in Japan have used dietary supplements or health foods
Authors
Shoichiro Ikuyama
Emiko Imamura-Takase
Shoji Tokunaga
Motohiro Oribe
Junji Nishimura
Publication date
01-06-2009
Publisher
Springer Japan
Published in
Modern Rheumatology / Issue 3/2009
Print ISSN: 1439-7595
Electronic ISSN: 1439-7609
DOI
https://doi.org/10.1007/s10165-009-0156-2

Other articles of this Issue 3/2009

Modern Rheumatology 3/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine